Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating immune responses in viral pneumonia and ARDS

Official title: Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress Syndrome

Run by University Hospital, Tours · NCT06720818 · Data updated 2026-11-12

This study looks at how certain immune cells behave in patients with viral pneumonia and ARDS to see if understanding them can help create better treatments.

More Acute Respiratory Distress Syndrome (ARDS) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity Hospital, Tours
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Tours)
StatusRecruiting
StartedMay 5, 2025
Main results expectedFebruary 2029
Study endsFebruary 2029
Registry record updatedMay 29, 2025
Trial IDNCT06720818 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are admitted to critical care for viral pneumonia or other specified conditions leading to ARDS.

Probably not a fit

Patients with severe immunosuppression may not benefit from this study due to their compromised immune response.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on understanding the role of Mucosal Associated Invariant T (MAIT) cells in patients suffering from viral pneumonia and Acute Respiratory Distress Syndrome (ARDS). The study aims to dissect the immunopathology of ARDS, particularly in cases related to SARS-CoV-2 and influenza A virus, to identify potential endotypes that could benefit from targeted therapies. By analyzing the activation mechanisms and functions of MAIT cells, the researchers hope to provide insights that could lead to new precision-medicine approaches for treating ARDS. Patients admitted to critical care units for specific conditions will be monitored to gather data on immune responses and tissue repair processes.

Why it matters

Potential benefit: If successful, this study could lead to the development of individualized therapies for patients with ARDS, improving their chances of recovery.

How similar studies have gone: While the role of MAIT cells in ARDS is being explored, this specific approach is relatively novel and has not been extensively tested in previous studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Patients admitted to critical care (Intensive Care Unit, Continuous Monitoring Unit, Intensive Care Unit) at the CHRU de Tours
* Patients admitted to critical care for one of the following reasons:

  * Acute community-acquired pulmonary infection (pneumonia),
  * Severe acute pancreatitis, with onset of ARDS criteria less than 48 hours ago,
  * Severe isolated head injury requiring invasive mechanical ventilation,
  * Severe burn defined by a burned surface area exceeding 20% and/or deep lesions exceeding 3% of the total body surface area, with the onset of ARDS criteria less than 48 hours ago,
  * Patient admitted to Intensive Care Medicine, requiring invasive mechanical ventilation,
  * Patient admitted to cardiac surgery for scheduled surgery for valve replacement and/or coronary artery bypass grafting, with inclusion the day before surgery,

Non-inclusion criteria :

* Patients with severe immunosuppression (impairing the ability to analyse the immune response, particularly T lymphocytes): active haematological malignancy, solid organ transplantation or bone marrow transplantation, systemic immunosuppressive treatment, ongoing chemotherapy (including immune checkpoint inhibitors).
* Person who has objected to data processing
* Patient under guardianship or curatorship

Where it's running

  • University hospital
    Tours, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.